Search for: "State v. Tri-State Pharmaceutical" Results 181 - 200 of 454
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Apr 2012, 10:34 am by Bexis
Thanks to Jim Fraser at Venable for passing along a nice fraudulent misjoinder finding in the Fosamax MDL, Welsh v. [read post]
3 Jun 2010, 1:37 pm by Bexis
This provision, along with the rebuttable-presumption . . . cede to FDA regulation some of this State's interest in policing local pharmaceutical manufacturers, thereby reducing New Jersey's interest in applying its law to this case.Id.In Devore v. [read post]
13 Sep 2007, 10:48 am
As mentioned above, the plaintiffs tried to get around the factual intricacies of "ascertainable loss" by claiming that experts could compute statistically some sort of "effect on the price" of a product by virtue of artificially increased demand that they claimed was generated by the improper marketing. 2007 WL 2493917, at *10. [read post]
21 Nov 2013, 12:13 pm
  The FDA’s brief cited Sigma-Tau Pharmaceuticals, Inc. v. [read post]
24 Aug 2023, 9:41 am by Annsley Merelle Ward
In parallel, Novartis tried to obtain preliminary injunctions (PIs) in several jurisdictions. [read post]
12 Mar 2020, 1:48 am by Sophie Corke
In line with Lord Justice Jacob’s point in Actavis v Merck, the Court of Appeal stated that – in certain circumstances – there is nothing inventive about routinely-taken steps even if the actual outcome had not been predicted. [read post]
27 Nov 2014, 4:08 pm
As he pointed out, if the New Jersey District Court had had to construe the 1955 agreement, it would not have applied federal common law principles: US contract law varied from state to state and there was no nationwide federal contract law available to apply. [read post]
Interestingly, the Judge also stated that there are means other than an application for summary judgment for showing that there is no serious issue to be tried. [read post]
30 Jun 2011, 5:00 am by Bexis
[He] has no basis to apply his opinions reliably to the pharmaceutical industry. [read post]
23 Jan 2014, 9:37 am by John Elwood
Merrell Dow Pharmaceuticals, Inc. [read post]